Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
3.970
0.00 (0.00%)
Aug 6, 2026, 4:00 PM EDT - Market closed
Bicycle Therapeutics Market Cap
Bicycle Therapeutics has a market cap or net worth of $277.15 million as of August 6, 2026. Its market cap has decreased by -49.08% in one year.
Market Cap
277.15M
Enterprise Value
-266.99M
1-Year Change
-49.08%
Ranking
Category
Stock Price
$3.97
ChartMarket Cap Chart
Since May 23, 2019, Bicycle Therapeutics's market cap has increased from $212.36M to $277.15M, an increase of 30.51%. That is a compound annual growth rate of 3.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 277.15M | -43.57% |
| Dec 31, 2025 | 491.12M | -49.19% |
| Dec 31, 2024 | 966.64M | 26.03% |
| Dec 29, 2023 | 766.98M | -12.72% |
| Dec 30, 2022 | 878.81M | -50.89% |
| Dec 31, 2021 | 1.79B | 367.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| OmniAb | 294.29M |
| SAB Biotherapeutics | 288.27M |
| Sol-Gel Technologies | 287.67M |
| Fulcrum Therapeutics | 287.64M |
| Foghorn Therapeutics | 286.52M |
| Lineage Cell Therapeutics | 284.20M |
| Immuneering | 284.02M |
| Turn Therapeutics | 280.90M |